𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glaxo-Wellcome merger and UK science base

✍ Scribed by Clare Thompson

Book ID
118557522
Publisher
The Lancet
Year
1995
Tongue
English
Weight
172 KB
Volume
345
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bioequivalence assessment of Lovrak (Jul
Bioequivalence assessment of Lovrak (Julphar, UAE) compared with Zovirax (Glaxo Wellcome, UK)-Two brands of Acyclovir-in healthy human volunteers
✍ Naji M. Najib; Nasir Idkaidek; Muntaser Beshtawi; B. Mohammed; Isra' Admour; S. πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 83 KB

Two studies were performed to assess the relative bioavailability of Lovrak (Julphar, UAE) compared with Zovirax (Glaxo Wellcome, UK) at the International Pharmaceutical Research Center (IPRC), Amman, Jordan. One study involved acyclovir tablets and the other acyclovir suspension. Each study enrolle

Efficacy of the neuraminidase inhibitor
Efficacy of the neuraminidase inhibitor GG167 in the treatment of influenza virus infections: F Hayden, Univ of Virginia, Charlottesville, VA; A Osterhaus, Erasmus Univ Hosp, Rotterdam; J Treanor, Univ of Rochester, Rochester, NY; D Fleming, Birmingham UK; F Aoki, Univ of Manitoba, Winnepeg; K Nicholson, Univ of Leicester, Leicester; H Hirst, Glaxo Wellcome, Inc. Research Triangle Park, NC; Oliver Keene, Kevin Wightman, Glaxo Wellcome plc, Greenford, UK
πŸ“‚ Article πŸ“… 1997 πŸ› Elsevier Science 🌐 English βš– 109 KB